Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Liminal BioSciences Inc. - Common Shares
(NQ:
LMNL
)
N/A
UNCHANGED
Last Price
Updated: 3:59 PM EDT, Sep 25, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
8.430 (1)
Ask (Size)
8.500 (25)
Prev. Close
8.500
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
31,042,560
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
↗
July 12, 2023
Gainers Healthcare Triangle, Inc. (NASDAQ: HCTI) shares climbed 171.2% to $8.84 as the company launched initiative to prevent ransomware attacks in the $35 billion healthcare data market.
Via
Benzinga
Liminal BioSciences Stock Gains0% Today - Here's Why?
↗
July 12, 2023
Liminal BioSciences Inc (NASDAQ: LMNL) shares are trading higher after Structured Alpha, a fund managed by Thomvest Asset Management, agreed to
Via
Benzinga
Performance
More News
Read More
Why SeaChange International Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
↗
April 06, 2023
Via
Benzinga
Liminal BioSciences Pulls Plug On Its Lead Development Program
↗
July 22, 2022
Via
Benzinga
Ocugen To Buy Liminal's Dormant Vaccine Manufacturing Plant In Canada
↗
January 27, 2022
Via
Benzinga
Dow Rises 80 Points; MarketAxess Holdings Shares Slide
↗
April 05, 2023
Via
Benzinga
Why Kura Sushi Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
↗
April 05, 2023
Via
Benzinga
Liminal Biosciences Inc. (NASDAQ: LMNL) Leading the Way in Wednesday Trading Based on Percentage Gain
April 05, 2023
Via
Investor Brand Network
Topics
Derivatives
Nasdaq Tumbles 150 Points; Liminal BioSciences Shares Spike Higher
↗
April 05, 2023
Via
Benzinga
Why Is Freight Technologies (FRGT) Stock Up 25% Today?
↗
April 05, 2023
Via
InvestorPlace
Why Is Liminal Biosciences (LMNL) Stock Up 77% Today?
↗
April 05, 2023
Via
InvestorPlace
Markets Mixed; US Trade Deficit Widens In February
↗
April 05, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
↗
January 03, 2023
Via
Benzinga
Earnings Scheduled For March 15, 2023
↗
March 15, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
↗
December 29, 2022
Via
Benzinga
Daily Biotech Pulse: VistaGen's Anxiety Study Fails, Silverback To Merge With Firm Developing EpiPen Alternative, Setback For Liminal's Lead Asset
↗
July 22, 2022
Via
Benzinga
Why Karuna Therapeutics Jumped Around 72%; Here Are 96 Biggest Movers From Yesterday
↗
August 09, 2022
Via
Benzinga
This Technology Stock Surged 235%; Here Are 77 Biggest Movers From Friday
↗
July 25, 2022
Via
Benzinga
Liminal BioSciences Outlines Plans To Further Develop Its Lead Compound
↗
March 14, 2022
Via
Benzinga
Americans’ Appetite for Vaccine Options Bodes Well for Ocugen
↗
February 21, 2022
Via
InvestorPlace
Liminal BioSciences Pauses Development Of Fezagepras, Outlines R&D Priorities For 2022
↗
January 20, 2022
Via
Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
↗
October 08, 2021
Via
Benzinga
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
↗
October 07, 2021
Via
Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
↗
October 06, 2021
Via
Benzinga
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
↗
October 05, 2021
Via
Benzinga
Frequently Asked Questions
Is Liminal BioSciences Inc. - Common Shares publicly traded?
Yes, Liminal BioSciences Inc. - Common Shares is publicly traded.
What exchange does Liminal BioSciences Inc. - Common Shares trade on?
Liminal BioSciences Inc. - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Liminal BioSciences Inc. - Common Shares?
The ticker symbol for Liminal BioSciences Inc. - Common Shares is LMNL on the Nasdaq Stock Market
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today